InvestorsHub Logo
Followers 45
Posts 5162
Boards Moderated 0
Alias Born 01/27/2012

Re: nidan7500 post# 107553

Wednesday, 06/07/2017 7:15:40 PM

Wednesday, June 07, 2017 7:15:40 PM

Post# of 459910
Its the same attitude we have been getting from wall street the entire ph 2a, + extensions. If someone questions the study or trial than they should contact the FDA because they designed the trial and Anavex is simply following their design.....which is unprecedented I might add.
All I'm saying is their may be a change in protocol in the wind from the old way of thinking with respect to placebo controlled trials being needed before approval. It would be fine to do a ph 3 and/or ph 4, Heck!..... placebo the hell out of it but their is no reason why patients should not be allowed access to a SAFE drug that BLOWS away SOC by leaps and bounds once a optimized dose is found all of which I believe the FDA is looking Dr. Missling at as we speak.

Tred
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News